Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca Askanase

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC StudySusan Manzi, Ian N Bruce, Eric F Morand, et al.
The Lancet. Rheumatology|August 29, 2024
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trialsIoannis Parodis, Julius Lindblom, Roger A Levy, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Lupus Science & Medicine|April 17, 2018
Lupus community panel proposals for optimising clinical trials: 2018Joan T Merrill, Susan Manzi, Cynthia Aranow, et al.
Journal of Lower Genital Tract Disease|March 8, 2022
Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple SclerosisAlyssa N Breneman, Ariel E Eber, Hoosna Haque, et al.
Arthritis Care & Research|July 26, 2018
The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York CountyPeter M Izmirly, Jill P Buyon, Isabella Wan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 12, 2017
The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance ProgramPeter M Izmirly, Isabella Wan, Sara Sahl, et al.
Rheumatology (Oxford, England)|December 20, 2022
Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance ProgramGhadeer Hasan, Elizabeth D Ferucci, Jill P Buyon, et al.
Annals of the Rheumatic Diseases|June 27, 2020
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating ClinicsArielle Mendel, Sasha Bernatsky, Anca Askanase, et al.
Lupus Science & Medicine|November 15, 2014
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurementsChaim Putterman, Richard Furie, Rosalind Ramsey-Goldman, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC StudySusan Manzi, Ian N Bruce, Eric F Morand, et al.
The Lancet. Rheumatology|August 29, 2024
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trialsIoannis Parodis, Julius Lindblom, Roger A Levy, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Lupus Science & Medicine|April 17, 2018
Lupus community panel proposals for optimising clinical trials: 2018Joan T Merrill, Susan Manzi, Cynthia Aranow, et al.
Journal of Lower Genital Tract Disease|March 8, 2022
Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple SclerosisAlyssa N Breneman, Ariel E Eber, Hoosna Haque, et al.
Arthritis Care & Research|July 26, 2018
The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York CountyPeter M Izmirly, Jill P Buyon, Isabella Wan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 12, 2017
The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance ProgramPeter M Izmirly, Isabella Wan, Sara Sahl, et al.
Rheumatology (Oxford, England)|December 20, 2022
Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance ProgramGhadeer Hasan, Elizabeth D Ferucci, Jill P Buyon, et al.
Annals of the Rheumatic Diseases|June 27, 2020
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating ClinicsArielle Mendel, Sasha Bernatsky, Anca Askanase, et al.
Lupus Science & Medicine|November 15, 2014
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurementsChaim Putterman, Richard Furie, Rosalind Ramsey-Goldman, et al.
Pageof 11